Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
Vale SA
VALE
KB Home
KBH
Apple
AAPL
US Stock MarketDetailed Quotes
NARI Inari Medical
- 79.930
- 0.0000.00%
Close Feb 14 16:00 ET
- 79.930
- 0.0000.00%
Post 20:01 ET
4.68BMarket Cap-59.21P/E (TTM)
79.970High79.930Low1.01MVolume79.940Open79.930Pre Close80.99MTurnover1.89%Turnover RatioLossP/E (Static)58.56MShares79.97052wk High10.77P/B4.29BFloat Cap36.73052wk Low--Dividend TTM53.69MShs Float127.420Historical High--Div YieldTTM0.05%Amplitude36.730Historical Low79.949Avg Price1Lot Size
About Inari Medical Company
Inari Medical, Inc. operates as a medical device company. The firm develops, manufactures, markets and sells devices for the interventional treatment of venous diseases. Its products include FlowTriever system and ClotTriever system. The company was founded by Brian J. Cox, Paul Lubock and Robert F. Rosenbluth in June 2011 and is headquartered in Irvine, CA.
Company Profile
SymbolNARI
Company NameInari Medical
Listing DateMay 22, 2020
Issue Price19.00
Founded2011
CEOMr. Andrew Hykes
MarketNASDAQ
Employees1300
Fiscal Year Ends12-31
Address6001 Oak Canyon,Suite 100
CityIrvine
ProvinceCalifornia
CountryUnited States of America
Zip Code92618
Phone1-877-923-4747
Websitehttp://www.inarimedical.com
Company Executives
- Name
- Position
- Salary
- Andrew Hykes
- Director, President and Chief Executive Officer
- 5.08M
- Dr. Thomas Tu, M.D.
- Chief Medical Officer
- 2.50M
- Kevin Strange
- Chief Financial Officer and Principal Accounting Officer
- --
- Donald Milder
- Chairman of the Board
- 266.43K
- William Hoffman
- Director
- 198.43K
- Cynthia L. Lucchese
- Independent Director
- 235.93K
- Dr. Jonathan D. Root,M.D.
- Independent Director
- 230.93K
- Rebecca Chambers
- Independent Director
- 220.93K
- Robert Warner
- Independent Director
- 220.93K
- Dana G. Mead, Jr
- Independent Director
- 218.43K
- Catherine M. Szyman
- Independent Director
- 220.47K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.